Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
CO ›
CO-EVOLVED MOLECULES
Trademark search for:
CO-EVOLVED MOLECULES
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-03-26 — Application filed
2021-07-01 — Application filed
2021-11-04 — Assigned to examiner
2021-11-05 — Final disposition recorded
2021-11-05 — Final disposition recorded
2021-11-05 — Final disposition recorded
2021-11-24 — Office action issued
2021-11-24 — Correspondence received in law office
2021-11-24 — Teas/email correspondence entered
2021-11-29 — Office action issued
2021-11-29 — Office action issued
2021-11-29 — Office action issued
2022-05-09 — Teas request for reconsideration received
2022-05-09 — Correspondence received in law office
2022-05-09 — Teas/email correspondence entered
2022-05-10 — Approved for pub - principal register
2022-05-25 — Notification of notice of publication e-mailed
2022-06-14 — Published for opposition
2022-06-14 — Official gazette publication confirmation e-mailed
2022-08-09 — Noa e-mailed - sou required from applicant
2023-02-06 — Sou teas extension received
2023-02-06 — Sou extension 1 granted
2023-02-06 — Sou extension 1 filed
2023-02-08 — Notice of approval of extension request e-mailed
2023-08-03 — Sou teas extension received
2023-08-03 — Sou extension 2 filed
2023-08-03 — Sou extension 2 granted
2023-08-05 — Notice of approval of extension request e-mailed
2024-02-06 — Sou teas extension received
2024-02-06 — Sou extension 3 filed
2024-02-06 — Sou extension 3 granted
2024-02-08 — Notice of approval of extension request e-mailed
2024-08-01 — Sou teas extension received
2024-08-01 — Notice of approval of extension request e-mailed
2024-08-01 — Sou extension 4 granted
2024-08-01 — Sou extension 4 filed
2025-02-09 — Sou extension 5 filed
2025-02-10 — Sou teas extension received
2025-05-21 — Sou extension 5 granted
2025-05-21 — Case assigned to intent to use paralegal
2025-05-22 — Notice of approval of extension request e-mailed
2025-09-15 — Application abandoned
2025-09-15 — Application abandoned
2025-09-15 — Final status recorded
Owner Information
Empress Therapeutics, Inc.
Empress Therapeutics, Inc.
Correspondent
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
